Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis

Maria Grazia Aprea; Irene Schiavetti; Emilio Portaccio; Chiara Ballerini; Simona Bonavita; Maria Chiara Buscarinu; Massimiliano Calabrese; Paola Cavalla; Maria Cellerino; Cinzia Cordioli; Vincenzo Dattola; Stefano de Biase; Ermelinda De Meo; Roberta Fantozzi; Antonio Gallo; Luigi Iasevoli; Rana Karabudak; Doriana Landi; Lorena Lorefice; Lucia Moiola; Paolo Ragonese; Francesca Ruscica; Sedat Şen; Leonardo Sinisi; Elisabetta Signoriello; Simona Toscano; Elena Pinuccia Verrengia; Aksel Sıva; Camilla Masciulli; Maria Pia Sormani; Maria Pia Amato

doi:10.1177/13524585241232266

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

In the general population, maternal COVID-19 is associated with worse maternal and fetal outcomes. Two previous studies have assessed COVID-19 clinical outcomes in pregnant women with multiple sclerosis (MS), but there are no data about maternal and fetal outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Aprea et al. (2024) studied this question.

synapsesocial.com/papers/68e74f77b6db6435876c7d4d https://doi.org/10.1177/13524585241232266

View Full Paper

Ask AI

Bookmark

Share

Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis

Ask about this paper

Abstract

Discussion

Cite This Study

Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading